BDFS Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BDFS Capital's ABBV Position: Q3 2026 in Review
BDFS Capital increased its AbbVie (ABBV) stake by 0.22% in Q3 2026, buying an estimated $513 and bringing the position to 901 shares worth $236K. The position accounts for 0.12% of the portfolio, ranked #106.
BDFS Capital first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- BDFS Capital held 901 shares of AbbVie worth $236K as of Q3 2026.
- BDFS Capital bought 2 AbbVie shares in Q3 2026, an estimated $513.
- AbbVie made up 0.12% of BDFS Capital's portfolio in Q3 2026, its #106 holding.
- BDFS Capital first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on BDFS Capital's 13F filing for Q3 2026, filed 14 Oct 2026.